awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28259540-238570FD-3031-48E3-8546-6B1608E53CF6
Q28259540-238570FD-3031-48E3-8546-6B1608E53CF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28259540-238570FD-3031-48E3-8546-6B1608E53CF6
What is new in the management of rapidly progressive glomerulonephritis?
P2860
Q28259540-238570FD-3031-48E3-8546-6B1608E53CF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28259540-238570FD-3031-48E3-8546-6B1608E53CF6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2caeb5fea454038ebd409abd8bfd7f6958b15b2f
P2860
Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy